Fig. 11

Protein-ligan interactions at the end of 100 ns molecular dynamics simulation. (A-B-C) Androgen receptor, P53-binding and cyclooxygenase-2 with 4-cadinene-3,11-diol; 3-(2-methylpropanoyl) and (D-E-F) Nuclear factor NF-kappa-B, mitogen-activated protein kinase 1, and binding poses of cyclin-dependent kinase 2 with (2-glyceryl)-O-coniferaldehyde, respectively